CVS Health (NYSE: CVS) is exploring a range of strategic alternatives for long-term care pharmacy Omnicare that could include a sale, according to the company’s top leader. The retail and pharmacy giant recorded a pre-tax loss on assets held for sale of $2.5 billion to write down Omnicare. As such, CVS Health President and CEO Karen Lynch said the company was “in the process of exploring strategic alternatives” for the long-term care pharmacy during a call with investors and analysts Wednesday.
Read the full article: CVS Health Exploring Sale of Long-Term Care Pharmacy Omnicare //
Source: https://seniorhousingnews.com/2022/11/02/cvs-health-exploring-sale-of-long-term-care-pharmacy-omnicare